Stock A261780 CHA VACCINE RESEARCH INSTITUTE
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart CHA Vaccine Research Institute

Equities

A261780

KR7261780001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 27/05/2024 BST 		5-day change 1st Jan Change
4,770 KRW +0.63% Intraday chart for CHA Vaccine Research Institute +1.49% -15.58%
01-08 CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy MT
2023 Cha Vaccine Research Institute Co., Ltd. announced that it has received KRW 10 billion in funding from EBEST Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CHA VACCINE RESEARCH INSTITUTE Stock CHA Vaccine Research Institute
 93.85M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 22.71B -
ARGENX SE Stock argenx SE
 21.83B -
GENMAB A/S Stock Genmab A/S
 18.18B
  1. Stock Market
  2. Equities
  3. A261780 Stock
  4. Charts CHA Vaccine Research Institute
  5. Sector Chart